In a statement on Saturday, WADA, which had appealed against the decision to clear Sinner to the Court of Arbitration for Sport (CAS), said it accepted Sinner’s explanation that he was inadvertently contaminated with the banned substance clostebol by his physio.
Sinner’s was the first of two high-profile cases in tennis in quick succession, with women’s world number two Iga Swiatek handed a one-month suspension in November after a positive test for the angina medication trimetazidine.
The world number one, who won the Australian Open last month, is suspended from February 9 until May 4, meaning he will be eligible to play in the year’s next Grand Slam, the French Open, which starts on May 19 at Roland Garros.
“Obviously having just won the Australian Open, to miss three months of the Tour and therefore to be eligible to play at Roland Garros, the timing couldn’t have been any better for Sinner, but I still think it leaves a pretty sour taste for the sport.
Sinner has reached a settlement with the World Anti-Doping Agency (WADA) over two positive drugs test in March last year.
